"To promote the high-quality development of Hainan's pharmaceutical and health industries, we need to take new actions." Recently, at the policy interpretation press conference of "Several Measures to Accelerate the Development of Digital Therapy Industry in Hainan Province", the interpreter Liu Zuokai told the reporter of Science and Technology Daily that Hainan would introduce relevant policies to increase the training of high-tech enterprises and technology-based SMEs in the field of digital therapy, and encourage the park to establish multiple platforms to support the rapid development of relevant enterprises. Liu Zuokai is one of the second batch of cadres sent to Hainan by the Organization Department of the Central Committee of the Communist Party of China in 2019. He is now the deputy director of the Science and Technology Department of Hainan Province. Only the innovator is strong, and only the innovator wins. Adhering to this belief, Liu Zuokai has embarked on the journey of exploring and promoting the bio pharmaceutical industry to make new breakthroughs and reach a new level in Hainan since he stepped on the hot land of booming development in the south of Shanghai in the summer of 2019. "At the beginning, I wanted to obey the organizational arrangements and participate in the implementation of the central decision-making and deployment in Hainan. With the accelerated pace of the construction of Hainan Free Trade Port, this pace is really unstoppable." Liu Zuokai said. "At present, China's medical science and technology is in the transition stage from imitation to innovation, and China is also moving from a large medical country to a powerful medical country. In 2019, Hainan Provincial Government, the Ministry of Science and Technology and the National Health Commission signed the Demonstration Framework Agreement on Jointly Promoting the Transfer and Transformation of Major National Science and Technology Special Achievements in Major New Drug Creation Hainan has become one of the only two pilot provinces in China. Hainan has unique ecological environment, geographical advantages and policy advantages, which make the modern biomedical industry in Hainan promising. " Liu Zuokai said. What are the weaknesses in Hainan's development of bio pharmaceutical industry? How to supplement? Liu Zuokai has participated in many research activities and analysis seminars, met with academicians, experts and entrepreneurs, shared professional insights, and discussed the future development trend of the industry. "Hainan adheres to reform and innovation, takes the lead and tries first, benchmarking against international standards, exploring the establishment of a policy system and platform conducive to the transfer and transformation of Hainan's major new drug discovery special achievements, and building a regional model for the national pilot demonstration of the transfer and transformation of major new drug discovery special achievements." Liu Zuokai told the Science and Technology Daily that Hainan is gradually forming a new path for industrial development with local characteristics. From 2020 to 2021, the Department of Science and Technology of Hainan Province, together with relevant provincial and municipal departments, parks and enterprises, will organize relevant personnel to go all over the country to focus on investment promotion and make precise efforts. A number of major industries and key projects will come one after another, providing a "jumping pole" for the industrial chain of Haikou National High tech Zone and Hainan Boao Music City International Medical Tourism Pilot Zone. During this period, Liu Zuokai traveled around Beijing and Hainan, actively communicating and coordinating with relevant departments to promote the policy blockage. He led the team to Shanghai, Jiangsu, Chengdu and other places for policy presentations, project screening, negotiation and signing. Today, Hainan's pharmaceutical industry is growing rapidly. Haikou National High tech Zone has achieved industrialization of 15 major new drug innovation achievements. Over the past three years, it has achieved an accumulative output value of nearly 4.6 billion yuan, and it is estimated that the total output value this year will reach 2 billion yuan; Hainan Boao Lecheng International Medical Tourism Pilot Area has built Hainan Stem Cell Engineering Center, successfully implemented two stem cell clinical research projects, and the pilot clinical real world data application in this pilot area has been promoted